The DOI matches its Crossref record; 49 of the 53 references it cites were found in a registry or an index.
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review
Open accessAbstract
Non-alcoholic fatty liver disease is a serious and growing clinical problem. Despite lifestyle modification, i.e. diet and physical activity, being the recommended therapy, there are currently no systematic evaluations of its efficacy. This review applies a systematic approach to evaluating lifestyle modifications studied to date. Medline (Pubmed), Scopus, and the Cochrane Controlled Trials Register were searched for studies and study groups assessing the effect of diet, physical activity, and/or exercise modification in adult populations with non-alcoholic fatty liver disease. The outcome markers of interest were indicators of steatosis, histological evidence of inflammation and fibrosis, and glucose control/insulin sensitivity. We identified 23 studies for inclusion; seven had control groups, but only six were randomised. Eleven groups received diet-only interventions, two exercise-only, and 19 diet and physical activity/exercise. Studies consistently showed reductions in liver fat and/or liver aminotransferase concentration, with the strongest correlation being with weight reduction. Of the 5 studies reporting changes in histopathology, all showed a trend towards reduction in inflammation, in 2 this was statistically significant. Changes in fibrosis were less consistent with only one study showing a significant reduction. The majority of studies also reported improvements in glucose control/insulin sensitivity following intervention. However, study design, definition of disease, assessment methods, and interventions varied considerably across studies. Lifestyle modifications leading to weight reduction and/or increased physical activity consistently reduced liver fat and improved glucose control/insulin sensitivity. Limited data also suggest that lifestyle interventions may hold benefits for histopathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A meta-analysis of lifestyle interventions in people with MASLD identified weight loss of between 4% and14% with a corresponding reduction in liver fat of 4–10%.27”
From Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD (2025) · cites this paper as [27]
Citations
Cites
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Self-citationSzczepaniak, L. S., Nurenberg, P., Leonard, D. S., Browning, J. D., Reingold, J. S., Grundy, S. M., Hobbs, H. H., & Dobbins, R. L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,573
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330
MOFRAD, P., Contos, M. J., Haque, M., Sargeant, C., Fisher, R. A., Luketic, V. A., Sterling, R. K., Shiffman, M. L., Stravitz, R. T., & Sanyal, A. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50229 · Cited by 1,199
Petersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911
Schwenzer, N. F., Springer, F., Schraml, C., Stefan, N., Machann, J., & Schick, F. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.023 · Cited by 751
Exercise for type 2 diabetes mellitus
Thomas, D., Elliott, E. J., & Naughton, G. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002968.pub2 · Cited by 728
Fracanzani, A. L., Valenti, L. V. C., Bugianesi, E., Andreoletti, M., Colli, A., Vanni, E., Bertelli, C., Fatta, E., Bignamini, D., Marchesini, G., et al. (2008) · Hepatology · doi:10.1002/hep.22429 · Cited by 716
Cited by
Sorted by citations
Items 401–500 of 523
TRUMP: A Trusted Mobile Platform for Self-management of Chronic Illness in Rural Areas
Burnett, C., Edwards, P. J., Norman, T. J., Chen, L., Rahulamathavan, Y., Jaffray, M., & Pignotti, E. (2013) · Lecture notes in computer science · doi:10.1007/978-3-642-38908-5_11 · Cited by 6
Ткач, С. М., & Чеверда, Т. Л. (2016) · Clinical endocrinology and endocrine surgery · doi:10.24026/1818-1384.1(53).2016.75839 · Cited by 6
What Is the Optimal Dietary Composition for NAFLD?
George, E. S., Tierney, A. C., Campbell, K. L., Macdonald, G. A., & Hickman, I. J. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0373-7 · Cited by 6
Gallego‐Durán, R., Ampuero, J., Funuyet, J., & Romero‐Gómez, M. (2013) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2013.06.005 · Cited by 6
Reinson, T., Bilson, J., Childs, C. E., Buchanan, R. M., Targher, G., & Byrne, C. D. (2026) · BMJ Medicine · doi:10.1136/bmjmed-2025-002038 · Cited by 9
Yang, L., Lin, W., Yan, X., & Zhang, Z. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112519 · Cited by 5
Wang, C.-L., Huang, W.-C., Chou, C., Lu, M., Huang, C.-J., Tsai, J. C.-S., & Tsai, P. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.05.041 · Cited by 5
Diagnosis and Management of Fatty Liver
Tan, P. O., Mustaffa, N., Tan, S. S., & Lee, Y. Y. (2020) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2020.308 · Cited by 5
Epidemiology and Comorbidities
Mathus-Vliegen, E. M. H., & Dargent, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-90074-2_1 · Cited by 5
Albor, C., Anyiam, O., Boyle, L., Makaronidis, J., Tan, R. J. L., Iftikhar, S., Burzić, A., Lajeunesse‐Trempe, F., Stanley, M., Bhatti, A. I., et al. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00707-6 · Cited by 5
Guan, R., Li, H., Jiao, Y., & Hong, Y. (2022) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-022-00479-1 · Cited by 7
Romero‐Gómez, M. (2022) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2022.09.004 · Cited by 5
HIV-Associated NAFLD: Disease Burden and Management
Kaplan, A. J., & Price, J. C. (2019) · Current Hepatology Reports · doi:10.1007/s11901-019-00501-0 · Cited by 4
Patanwala, I., Molnar, L. E., Akerboom, K., & Lane, K. E. (2020) · Frontline Gastroenterology · doi:10.1136/flgastro-2020-101669 · Cited by 4
Green space exposure during pregnancy and umbilical cord blood levels of liver enzymes
Mehrabadi, S., Miri, M., Najafi, M. L., Ghalenovi, M., Adli, A., Pajohanfar, N. S., Ambrós, A., Dovlatabadi, A., Estiri, E. H., Abroudi, M., et al. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-20568-5 · Cited by 4
Hígado graso no alcohólico en consulta de gastroenterología
Edwin Ochoa, C., & Calambás, F. H. (2017) · Revista Repertorio de Medicina y Cirugía · doi:10.1016/j.reper.2017.10.005 · Cited by 4
Omega-3 Fatty Acids and Fatty Liver Disease in Children
Corte, C. D., Iasevoli, S., Strologo, A. D., Sanseviero, M., & Nobili, V. (2018) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2018.03.001 · Cited by 4
Zhu, B. J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1753393 · Cited by 3
Scanarotti, I. G., Saín, J., Fabro, A. P., & Bernal, C. (2024) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.202300203 · Cited by 3
Supaglutide alleviates hepatic steatosis in monkeys with spontaneous MASH
Wang, Q., Zhou, Y., Ni, Y., Wang, Z., Lou, Y.-R., Yang, Z., Gong, L., Liang, Y., Zeng, W., & Prud’homme, G. J. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01513-7 · Cited by 3
Kelty, T. J., Krause, A. A., & Rector, R. S. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00178.2025 · Cited by 3
The main approaches to dietary changes in non-alcoholic fatty liver disease
Drapkina, O. M., Шепель, Р. Н., Starodubova, A. V., & Evsutina, Y. V. (2018) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20182106178 · Cited by 3
Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease
Jukić, L. V. (2021) · Acta Clinica Croatica · doi:10.20471/acc.2021.60.s1.03 · Cited by 3
Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease
Andreev, K. A., Skirdenko, Y. P., Николаев, Н. А., Livzan, M. A., Горбенко, А. В., Fedorin, M. M., & Сергеевна, К. Т. (2022) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2021-4-112-122 · Cited by 4
Obesity and nonalcoholic fatty liver disease
Chitturi, S. (2014) · ANU Open Research (Australian National University) · doi:10.3978/j.issn.2224-4778.2014.07.02 · Cited by 3
Adkins, Y. C., Fedor, D. M., Mackey, B. E., Wu, J., & Kelley, D. S. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.11.028 · Cited by 3
Hatami, M. T., & Eftekhari, E. (2016) · Biotechnology and Health Sciences · doi:10.17795/bhs-36162 · Cited by 3
Ahmad, A., & Ali, H. M. (2020) · Advances in Rehabilitation · doi:10.5114/areh.2020.100186 · Cited by 3
Short-term Dietary Interventions for the Management of Nonalcoholic Fatty Liver
Stokes, C. S., Lammert, F., & Krawczyk, M. J. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170508144409 · Cited by 3
Treatment of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)
Bril, F., Ntim, K., Lomonaco, R., & Cusi, K. J. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch20 · Cited by 3
Rospleszcz, S., Burger, T., Addin, N. S., Kiefer, L. S., Diallo, T. D., Wawro, N., Schlett, C. L., Bamberg, F., Peters, A., Gedrich, K., et al. (2025) · Nutrition Journal · doi:10.1186/s12937-025-01222-5 · Cited by 3
Treating the patient with nonalcoholic fatty liver disease
Chaney, A. J. (2015) · The Nurse Practitioner · doi:10.1097/01.npr.0000472248.28703.18 · Cited by 2
Rahimpour, Z., Hoseini, R., & Behpour, N. (2022) · Middle East Journal of Digestive Diseases · doi:10.34172/mejdd.2022.277 · Cited by 2
Heredia, N. I., Duque, E. M., Ayieko, S. A., Averyt, A., McNeill, L. H., Hwang, J. P., & Fernández, M. E. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-084411 · Cited by 2
NON-ALCOHOLIC FATTY LIVER DISEASE AND EXTRA-HEPATIC CANCER: A NARRATIVE REVIEW
de Rezende, A. Q. M., & Cazzo, E. (2024) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.24612023-027 · Cited by 2
Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
Pitchumoni, C. S., Pitchumoni, C. S., & Pitchumoni, C. S. (2012) · Springer eBooks · doi:10.1007/978-1-4419-1623-5_40 · Cited by 2
Dealing with abnormal test results in diabetes
Morris, D., & Morris, S. (2016) · Independent Nurse · doi:10.12968/indn.2016.12.22 · Cited by 2
Giangrandi, I., Dinu, M., Pagliai, G., Sofi, F., & Casini, A. (2016) · Alternative & Integrative Medicine · doi:10.4172/2327-5162.1000224 · Cited by 2
Yoh, K., Nishikawa, H., Enomoto, H., Iwata, Y., Ishii, A., Yuri, Y., Ishii, N. K., Miyamoto, Y., Hasegawa, K., Nakano, C., et al. (2017) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2017-000185 · Cited by 2
Medical Approach for Weight Loss in Nonalcoholic Fatty Liver Disease
Do, A., Ilagan‐Ying, Y. C., & Mehal, W. Z. (2019) · Current Hepatology Reports · doi:10.1007/s11901-019-00498-6 · Cited by 2
Physical Activity in NAFLD: What and How Much?
Hallsworth, K., & Trenell, M. I. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_16 · Cited by 3
Non-alcoholic Fatty Liver Disease
Marjot, T., & Cobbold, J. (2016) · In clinical practice · doi:10.1007/978-3-319-43126-0_7 · Cited by 2
ElDeeb, A. M., Elsisi, H. F. E. M., & Lasheen, Y. R. (2018) · Bulletin of Faculty of Physical Therapy · doi:10.4103/bfpt.bfpt_6_18 · Cited by 2
A Primary Care Perspective of Fatty Liver: Diagnosis, Management, Prescribing, and when to Refer
Chitturi, S., & Farrell, G. C. (2013) · doi:10.1002/9781118556153.ch8 · Cited by 2
Njei, B. M., Ameyaw, P. A., Al‐Ajlouni, Y. A., Njei, L., & Boateng, S. (2024) · Research Square · doi:10.21203/rs.3.rs-3940574/v1 · Cited by 2
Kahal, H. (2013) · Repository@Hull (Worktribe) (University of Hull) · Cited by 2
Heredia, N. I., John, J. C., Singh, S. K., Hwang, J. P., Strong, L. L., Balakrishnan, M., & McNeill, L. H. (2024) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580241241272 · Cited by 1
Huang, X., Yu, R., Guo, M., Tan, X., Xia, Y., Zou, H., Liu, X., & Qin, C. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf145 · Cited by 2
Shi, X., Song, H., Xiong, X., Wei, S., Zhang, L., You, S., Zhou, W., Ji, G., Liu, B., & Wu, N. (2026) · Clinical Epigenetics · doi:10.1186/s13148-025-01950-9 · Cited by 1
Sun, W.-J., Xing, L.-L., Zhao, S.-F., & Ying, H. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1790674 · Cited by 1
Non-pharmacological treatment of MASLD
Dufour, J., & Berzigotti, A. (2026) · Diabetologia · doi:10.1007/s00125-026-06811-5 · Cited by 1
Nonalcoholic Fatty Liver Disease: Lifestyle Modification
Yoo, K. D., & Jun, D. W. (2014) · Korean Journal of Medicine · doi:10.3904/kjm.2014.86.4.416 · Cited by 1
Non-Alcoholic Fatty Liver Disease – Changing the Prevalence of Liver Cancer?
Campana, B., Semela, D., Heim, M. H., & Bernsmeier, C. (2015) · EMJ Hepatology · doi:10.33590/emjhepatol/10314903 · Cited by 1
Dietoterapia em um Paciente Hepatopata Hospitalizado: Adequação do Perfil Lipídico
da Silva, L. S. A., Hairrman, R. S., Calças, N. C., de Oliveira, R. A. M., Barão, Y. F., Lopes, E. F. B., Rotta, C. D. S., de Menezes, I. R., Galete, J., Soares, M. D., et al. (2020) · Brazilian Journal of Development · doi:10.34117/bjdv6n1-324 · Cited by 1
Plauth, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98368-6.00004-5 · Cited by 1
Nichtalkoholische Fettlebererkrankungen
Roeb, E., & Canbay, A. E. (2016) · Die Gastroenterologie · doi:10.1007/s11377-016-0063-y · Cited by 1
Non-alcoholic Fatty Liver Disease
Koeckerling, D., Marjot, T., & Cobbold, J. (2022) · In clinical practice · doi:10.1007/978-3-031-10012-3_7 · Cited by 1
S., L. C., & Guillermo Silva, P. (2015) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2015.09.006 · Cited by 1
Galvis, O. A. B., Galindo, A., Mendoza, Y. P., Hernández, G., Garzón, M., Prieto, J. E., Pardo, R., Otero, R. W., & Sabbagh, L. C. (2015) · Cited by 1
Akhtar, S., & Khan, A. U. (2020) · Advanced Journal of Graduate Research · doi:10.21467/ajgr.9.1.46-58 · Cited by 1
Chávez-Tapia, N. C., Barrientos‐Gutiérrez, T., Torres‐Ibarra, L., Sánchez-Jimenez, B., Juárez-Hernández, E., Ramos-Ostos, M. H., Alva-López, L. F., & Uribe, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-12295-1 · Cited by 1
What is Non‐Alcoholic Fatty Liver Disease (NAFLD), and Why is it Important?
Farrell, G. C., McCullough, A. J., & Day, C. P. (2013) · doi:10.1002/9781118556153.ch1 · Cited by 1
Hickman, I. J., Macdonald, G. A., & Byrne, N. M. (2013) · Wiley eBooks · doi:10.1002/9781118556153.ch12 · Cited by 1
Editorial: diabetes in HIV ‐infected patients—do not blame the usual suspect!
zu Siederdissen, C. H., & Mederacke, I. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14863 · Cited by 1
LIFESTYLE CHANGES IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE: A SYSTEMATIC REVIEW PROTOCOLPreprint
Fernández, T., Macarena Viñuela, M., Arrese, M. A., Arab, J. P., Cabrera, D., & Francisco Barrera, M. (2020) · medRxiv · doi:10.1101/2020.06.22.20137430 · Cited by 1
Darbandi, M., Hamzeh, B., Ayenepour, A., Rezaeian, S., Najafi, F., Shakiba, E., & Pasdar, Y. (2020) · Research Square · doi:10.21203/rs.3.rs-130173/v1 · Cited by 1
Esmaeili, S. (2022) · Research Square · doi:10.21203/rs.3.rs-2094137/v1 · Cited by 1
Kheirdoust, A., Habibi, M. R. M., Emadzadeh, A., Esfehani, A. J., Nia, R. G. N. N., & Eslami, S. (2023) · doi:10.2196/preprints.51143 · Cited by 1
Mellberg, C. (2014) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Gurusamy, K. S., Thorburn, D., Davidson, B. R., & Tsochatzis, E. A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011640
Selection Of Optimal Wavelet Packet Transforms For Object-Based Coding
Doulamis, A. D., Doulamis, N. D., Stephanakis, I. M., & National, S. D. K. (2000) · doi:10.5281/zenodo.37154
Glucagon-like peptide-1 in nonalcoholic steatohepatitis
Armstrong, M. J. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
Non-alcoholic fatty liver disease in patients with diabetes mellitus
Naini, S. R., & Fuchs, M. A. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.938053
Hígado graso no alcohólico. Papel de los médicos de atención primaria
Caballería, J., & Caballería, L. (2015) · Medicina Clínica · doi:10.1016/j.medcli.2015.04.012
Non-alcoholic fatty liver disease. Role of primary care physicians
Caballería, J., & Caballería, L. (2015) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2016.01.002
Current and Emerging Therapies for Nonalcoholic Fatty Liver Disease
Gawrieh, S., & Chalasani, N. (2015) · Springer eBooks · doi:10.1007/978-3-319-20538-0_16
A Review of Pharmacological Treatments of NASH
de Siqueira, É. R. F. (2015) · Gastroenterology & Hepatology Open Access · doi:10.15406/ghoa.2015.02.00058
Diabetes and Non‐Alcoholic Fatty Liver Disease
Chitturi, S., & Farrell, G. C. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch51
Diet-induced phenotypic plasticity during aging
Rusli, F. (2016) · doi:10.18174/387386
Bécares, N., Gage, M., Martin‐Gutierrez, L., Shrestha, E., Louie, R., Pourcet, B., Pello, Ó. M., Luong, T. V., Goñi, S., Liang, N., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/127779
Avaliação da vitamina D na doença hepática gordurosa não alcoólica
de Paula, F. V. L. (2017) · doi:10.11606/d.17.2017.tde-30032017-094325
El-Kader, S. M. A. (2017) · Advanced Research in Gastroenterology & Hepatology · doi:10.19080/argh.2017.03.555608
Badr, N. M., El-Sayed, S. H., Batanony, E., Attia, D. I., & Ali, H. (2016) · Egyptian Journal of Occupational Medicine · doi:10.21608/ejom.2016.831
Role of Exercise in NAFLD/NASH: What is the Right Prescription?
Bertot, L. C., & Adams, L. A. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0374-6
Affect of late-onset prenatal care on antenatal diagnosis.
Bodurtha, J. N., Corey, L., & Nance, W. E. (1986) · PubMed
Ranasinghe, D. C. (2018) · Queensland University of Technology · doi:10.5204/thesis.eprints.115457
Editorial: weight change, liver histology and the metabolic effects of obeticholic acid in NASH
Eslam, M., & George, J. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14547
Pitriani, P., Park, H.-G., & Lee, W.-L. (2019) · International Conference on Sport Science, Health, and Physical Education (ICSSHPE) · doi:10.2991/icsshpe-18.2019.49
An investigation of ambulatory tertiary hospital resource utilisation by people with liver disease
El-Atem, N. A. (2020) · Queensland University of Technology · doi:10.5204/thesis.eprints.180900
Manejo de la enfermedad hepática metabólica grasa
Lucena, A., Torrijo, Y. S., & Herrojo, J. A. (2020) · Revista Andaluza de Patología Digestiva · doi:10.37352/2020432.2
Cordes, C. (2018) · mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich)
Self-Management in Nutrition and Exercise
Clookey, S. L. (2021) · Springer eBooks · doi:10.1007/978-3-030-69736-5_11
E-Manuscript Article Summaries
Current Oncology Editorial Office (2011) · Current Oncology · doi:10.3747/co.v18i2.897
Moore, M. P. (2021) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/91011
Wang, S., Wang, P., Zhang, Q., Luo, T., & Qin, B. (2022) · Research Square · doi:10.21203/rs.3.rs-1965788/v1
Lifestyle and Nonalcoholic Steatohepatitis
王, 巧. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.12111528
The impact of very-low-calorie diets on ectopic fat deposition
Rayner, J. J., & Abdesselam, I. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822186-0.00008-0
Metadata
- Authors
- Thoma, C., Day, C. P., & Trenell, M. I.
- Affiliations
- Newcastle University (GB)
- Corresponding author
- Trenell, Michael I.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 56
- Issue
- 1
- Pages
- 255-266
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2010662354
- Cited by
- 523
- References
- 53
- Citations by year
- 2026: 14 · 2025: 17 · 2024: 30 · 2023: 37 · 2022: 35 · 2021: 43 · 2020: 42 · 2019: 36 · 2018: 32 · 2017: 46 · 2016: 46 · 2015: 46 · 2014: 40 · 2013: 32 · 2012: 23
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Hepatology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- National Institute for Health and Care Research (SRF-2011-04-017)
- Medical Research Council (MC_G0802536)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- non-alcoholic fatty liver disease, lifestyle intervention, dietary intervention, physical activity, weight loss, liver fat, hepatic steatosis, liver fibrosis, liver inflammation, insulin sensitivity, glycemic control, transaminases
- MeSH terms
- Adult, Aged, Clinical Trials as Topic, Combined Modality Therapy, Diet Therapy, Exercise Therapy, Fatty Liver, Female, Humans, Life Style, Male, Middle Aged, Motor Activity, Prospective Studies, Lipid Metabolism, Weight Reduction Programs, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review